Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

for
Lung Cancer, Non-small Cell, Lung Cancer Metastatic,
Location: Nasville TN, Dothan AL, Canton OH, New Orleans LA,
Sponsor: Krystal Biotech, Inc.

Sex: All

Age: 18+

Code: NCT06228326

Phase 1, Phase 2, Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

for
Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma,
Location: Nashville TN, St Louis MO, Huntersville NC,
Sponsor: Aulos Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05267626

Phase 1, Phase 2, Recruiting

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

for
Multiple Myeloma
Location: Nashville TN, Atlanta GA, Indianapolis IN, St Louis MO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05201781

Recruiting

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Nashville TN, Jacksonville FL, Fairfax VA, Tampa FL,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05954312

Phase 1, Recruiting

SNV4818 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Nashville TN, Toronto, Houston TX, Philadelphia PA,
Sponsor: Pikavation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06736704

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: Nashville TN, Durham NC, Cleveland OH, Pittsburgh PA,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase 1, Phase 2, Recruiting

Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma

for
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma,
Location: Nashville TN, Ann Arbor MI, Tampa FL, Houston TX,
Sponsor: Remix Therapeutics

Sex: All

Age: 18+

Code: NCT06118086

Phase 1, Phase 2, Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Solid Tumor, Adult,
Location: Nashville TN, Atlanta GA, Augusta GA, Little Rock AR,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 19+

Code: NCT06586957

Phase 1, Recruiting

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

for
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute,
Location: Nashville TN, Columbus OH, Chicago IL, Madison WI,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06501196

Phase 1, Recruiting

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

for
Metastatic Non-small Cell Lung Cancer
Location: Nashville TN, Tampa FL, Baltimore MD, Houston TX,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04410796

Phase 2, Recruiting

Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma

for
Multiple Myeloma
Location: Nashville TN, Cincinnati OH, Chapel Hill NC, Durham NC,
Sponsor: Prolexys Pharmaceuticals

Sex: All

Age: 18+

Code: NCT01695590

Phase 1, Phase 2, Recruiting

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

for
Solid Tumor, MET Alteration
Location: Nashville TN, Canton OH, Washington D.C. DC
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT06669117

Phase 1, Phase 2, Recruiting

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Nashville TN, Cincinnati OH, Huntersville NC, Durham NC,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06040541

Phase 1, Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for
Breast Cancer, Solid Tumors, Adult
Location: Nashville TN, Atlanta GA, Germantown TN, St Louis MO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05768139

Phase 1, Phase 2, Recruiting

A Study of JNJ-87890387 for Advanced Solid Tumors

for
Neoplasms, Advanced Solid Tumors
Location: Nashville TN, Grand Rapids MI
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06178614

Phase 1, Recruiting

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

for
Solid Tumors, Sarcoma
Location: Nashville TN, New York NY, Boston MA
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644755

Phase 1, Recruiting

A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors

for
Triple Negative Locally Advanced Non-resectable Breast Cancer,
Location: Nashville TN, Columbus OH, Toronto, San Antonio TX,
Sponsor: Marengo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06827613

Phase 1, Phase 2, Recruiting

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Nashville TN, Durham NC, Myrtle Beach SC, Metairie LA,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT06800313

Phase 1, Phase 2, Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

for
Triple Negative Breast Cancer, Breast Cancer,
Location: Nashville TN, Atlanta GA, Chicago IL, Jacksonville FL,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05377996

Phase 1, Phase 2, Recruiting

Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

for
Relapsed Classic Hodgkin Lymphoma
Location: Nashville TN, Chicago IL, Hackensack NJ, Boston MA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04561206

Phase 2, Recruiting